IFNAR2 and chronic hepatitis C virus infection: Chronic hepatitis C patients’ carriers of the rs2229207 C allele (IFNAR2) and combined treatment with pegylated-interferon-alpha (PEG IFN-alpha) and ribavirin showed an association (p = 0.02) with the increased risk (OR, 2.07) of presenting a sustained virological response (SVR).